title: [Triclabendazole].
abstract: Triclabendazole is indicated for treatment of human fascioliasis, a widespread disease. Treatment is straightforward and generally well tolerated. However, increasing resistance to this therapy has been observed since the 1990s. Research is being carried out to develop new medications with special interest in artesunate.
authors.affiliation: Service de Pharmacie Hospitalière, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Boulliat
authors.forename: A
authors.initials: A
authors.lastname: Wolf
authors.forename: K
authors.initials: K
authors.lastname: Gaillard
authors.forename: M
authors.initials: M
authors.lastname: Oliver
mesh_terms: D000871:Anthelmintics / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D005211:Fascioliasis / Q000188:drug therapy; D006801:Humans; D000077682:Triclabendazole
chemical_list: D000871:Anthelmintics; D001562:Benzimidazoles; D000077682:Triclabendazole